A study published in BMJ Gut examined “the association between the regular use of proton pump inhibitors (PPI) and the risk of type 2 diabetes.”
The study followed over 200,000 participants who did not have diabetes prior to the follow-up study. During the follow up, the researchers confirmed over 10,000 cases of diabetes. Additionally, they found that the regular PPI users had a “24% higher risk of diabetes than non-users.”
Though more research is needed in this area, these types of results may indicate a need for healthcare professionals to education their patients on PPI and “exercise caution when prescribing PPIs.”
Click here to read the full study.